The Effect of Endogenous GLP-1 on Glucagon Secretion in Type 1 Diabetes
NCT07373236
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes
Interventions
DRUG:
exendin(9-39)amide
DRUG:
Saline (0.9% NaCl)
Sponsor
Asger Lund, MD